Posts Under ‘Cancer Research’ Category

Hats Off To Eric Lefkfosky

Eric Lefkfosky is the co-founder and CEO of Tempus Laboratory based in Chicago, Illinois. The Tempus Company has been in operation since 2015. Since its inception over 210 million dollars has been invested in into the company to undergird their support of Clinical Trials, Health Care, Health Diagnostics in the medical health communities. The Tempus…Continue Reading…

The Inspirational Entrepreneur-Erick Lefkofsky.

Entrepreneurship refers to the process of starting and running businesses with an aim of making profits. Some scholars have argued that the entrepreneurial skills are inborn while others are acquired during a person’s life. The entrepreneurs have some certain distinct characteristics that set them apart from other business people, for example, they are innovative and…Continue Reading…

Eric Lefkofsky: Introducing New Medical Procedures

One of the leading innovators in the field of medicine and medicinal research is Eric Lefkofsky. He is most well-known for establishing Tempus, and he is the current chief executive officer of the company. Tempus is a tech company focusing on innovating the science of medicine. One of the most ambitious projects that Tempus created…Continue Reading…

InnovaCare Health Inc. Chief Executive Officer Dr. Rick Shinto

Doctor Rick Shinto was appointed as the CEO of InnovaCare Inc. in the year 2012. Appointing him as the president of the company was the best step to take because it did not take him long before he was noticed as an effective and inspiring leader. As the CEO, he works to make certain that…Continue Reading…

Clay Seigall and the Future of Cancer Research

  There are few more promising companies involved in the field of cancer research than the biotech company, Seattle Genetics. The company is mainly known for it’s affinity for innovation in non invasive cancer therapy treatments. Seattle Genetics stock price has increased three-fold over the period of just five years, which shows just how much…Continue Reading…